As a five-time MMIT Patient Choice Award Winner with a portfolio of 25+ rare programs, PANTHERx attributes much of our success to our ability to hire and cultivate talent while simultaneously investing in state-of-the-art proprietary technology systems. With the expected surge of FDA rare medication approvals over the next decade, talent and technology will become […]

PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the first quarter of 2022, PANTHERx obtained the highest Net Promoter Score (NPS) among all independent specialty pharmacies surveyed. Net Promoter Score (NPS) is compiled by asking patients, on […]

Change has been a constant in the specialty pharmacy industry since its inception over two decades ago. New medications are routinely launched, more patient populations receive treatment, and public awareness of rare diseases has increased. Additionally, industry players and their specialty pharmacy management strategies have evolved to meet the needs of increasingly complicated treatments and […]

The History of Rare Disease Day On February 29th, 2008, EURORDIS, a non-profit patient alliance of now nearly one thousand organizations from 73 countries, celebrated the first Rare Disease Day with its Council of National Alliances across Europe. Leap Day was specifically chosen for this special designation as it is a “rare” day that occurs […]

This past year has proven to be one of record patient satisfaction scores for PANTHERx Rare. In the first half of 2021, PANTHERx led the independent specialty pharmacy category of the MMIT Patient Satisfaction survey with quarterly Net Promoter Scores (NPS) of 96 and 97. Net Promoter Score (NPS) is compiled by asking patients, on […]